The breast cancer genetic risk-based stratified screening service was introduced at the European Society of Human Genetics Conference: preliminary results of the EIT Health BRIGHT project in Estonia.

Periodic reinterpretation of genetic sequencing results presents a challenge for developing transparent and systematic coverage and reimbursement policies. Continuing advances in genetic sequencing ...

Myriad Genetics, Inc. announced in a press release that a study published in JCO Precision Oncology indicates their RiskScore® tool enhances breast cancer screening by aligning clinician ...

Every patient deserves to know if their breast cancer is hereditary, if their treatment could be more precise and if their ...

Remote clinical pharmacist impact on reducing total cost of care in Enhancing Oncology Model–enrolled oncology practices. Electronic patient-reported outcome-based weight management versus usual care ...